TTC-352

SKU: orb1739081

Description

TTC-352 is an orally active, selective ERα partial agonist (ShERPA) with antineoplastic potential. It binds ERα, inducing its nuclear export to disrupt normal estrogen signaling and inhibit proliferation in ER-positive cancer cells. This mechanism has been investigated in both in vitro assays and in vivo xenograft models of breast cancer research.

Research Area

Metabolism Research

Key Properties

• CAS Number: 1607819-68-0
• MW: 352.38
• Formula: C₂₀H₁₃FO₃S
• SMILES: O(C1=C(C=2C(S1)=CC(O)=CC2)C3=CC=C(F)C=C3)C4=CC=C(O)C=C4
• Target: Estrogen Receptor/ERR,Others

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Compound Identifiers

PubChem CID

74222430